X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

LSTA

Closed

Lisata Therapeutics Inc.

2.86
-0.04 (-1.38%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.8991
Day's Range: 2.82 - 2.93
Send
When Written:
 
3.08
Lisata Therapeutics Inc. is a biotechnology company that focuses on developing novel gene therapies for the treatment of inherited diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. Lisata's gene therapy platform is based on a proprietary technology called CRISPR/Cas9, which allows for precise editing of genetic material. The company's lead program is focused on developing a gene therapy for the treatment of beta-thalassemia, a genetic blood disorder. Lisata is also exploring the potential of its gene therapy platform in other disease areas, including sickle cell disease and cystic fibrosis.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X